Evidence map›Paper›PMID 33603091›Full record

ArticleScientific reports2021

Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent.

Maxime Bélondrade, Simon Nicot, Charly Mayran, Lilian Bruyere-Ostells, Florian Almela, Michele A Di Bari, Etienne Levavasseur, Joel C Watts, Chantal Fournier-Wirth, Sylvain Lehmann and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Maxime Bélondrade *Pathogenesis and Control of Chronic Infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France.
Simon Nicot *Pathogenesis and Control of Chronic Infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France.
Charly MayranPathogenesis and Control of Chronic Infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France.
Lilian Bruyere-OstellsPathogenesis and Control of Chronic Infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France.
Florian AlmelaPathogenesis and Control of Chronic Infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France.
Michele A Di BariDepartment of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanita, Rome, Italy.
Etienne LevavasseurInserm U 1127, CNRS UMR 7225, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Sorbonne Universités, Paris, France.
Joel C WattsTanz Centre for Research in Neurodegenerative Diseases and Department of Biochemistry, University of Toronto, Toronto, Canada.
Chantal Fournier-WirthPathogenesis and Control of Chronic Infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France.
Sylvain LehmannIRMB, INM, INSERM, CHU Montpellier, (LBPC-PPC), Univ Montpellier, Montpellier, France.
Stéphane HaïkInserm U 1127, CNRS UMR 7225, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Sorbonne Universités, Paris, France.
Romolo NonnoDepartment of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanita, Rome, Italy.
Daisy BougardPathogenesis and Control of Chronic Infections, Etablissement Français du Sang, Inserm, Université de Montpellier, Montpellier, France. daisy.bougard@efs.sante.fr.
Établissement Français du Sang · FRInserm · FRIstituto Superiore di Sanità · ITCentre National de la Recherche Scientifique · FRSorbonne Université · FRUniversity of Toronto · CA

Funding

Agence Nationale de Sécurité du Médicament et des Produits de Santé PrionMDsecure
6 · The paper itself

Abstract

Unlike variant Creutzfeldt-Jakob disease prions, sporadic Creutzfeldt-Jakob disease prions have been shown to be difficult to amplify in vitro by protein misfolding cyclic amplification (PMCA). We assessed PMCA of pathological prion protein (PrP

Indexed as

AnimalsArvicolinaeCreutzfeldt-Jakob SyndromeHumansMiceMice, TransgenicPrion ProteinsPrionsProtein FoldingProteostasis DeficienciesPrion ProteinsPrions

Identifiers

PMID33603091
PMCPMC7893054
OpenAlexW3129402656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.